We want your "vintage" industry technology photos!

The ddRCruze is Swissray’s answer to portable imaging flexibility. Compact, fully motorized and mobile this DR system can be easily operated with one hand. Bedside or any other area of the hospital, it delivers superb image quality, seamlessly connects to hospital networks and delivers maximum workflow efficiency. We asked technologists to help us design the perfect mobile system. With their feedback we developed a system with features to make the work day “Cruze“ by.

A new era of telehealth has arrived. According to HIMSS Analytics 3rd Annual Mobile Survey, 83 percent of physicians use mobile technology to provide care. Because doctors are so mobile, patient information has to be mobile as well. The goal of telehealth is to eliminate geographic constraints and deliver quality patient care at any time, in any location.1 Many healthcare providers have shown an increasing interest in telehealth because of the benefits it can provide, among them, greater access to patient data and images, lower costs and higher quality of care. Offerings of telehealth include consumer online access to providers for diagnosis and treatment of common ailments, real-time video-based virtual consults between providers and patients, in-home monitoring of chronically ill patients, and primary care physicians’ access to specialists for consultation and diagnosis.

Angiographic imaging system vendors have developed several new technologies to address emerging cath lab trends, including the need to reduce radiation dose, improve image quality and enable advanced procedural image guidance. All three of these points have become increasingly important as more complex procedures are attempted in interventional labs and hybrid ORs. These procedures include embolic coiling, neuro-interventions, thrombectomy, aortic repair, transcatheter aortic valve replacement (TAVR), mitral clip valve repairs, left atrial appendage (LAA) occlusions, atrial and ventricular septal defect closures, and new interventions for both electrophysiology (EP) and heart failure.

EOS Imaging announced that the U.S. Food and Drug Administration (FDA) has cleared the Micro Dose feature of the EOS imaging system for pediatric imaging.

Based on its recent analysis of the medical imaging informatics market, Frost & Sullivan recognized Calgary Scientific Inc. with the 2014 North American Frost & Sullivan Award for Growth Capital Investment Opportunity.